Castelló A, Rodríguez-Manzaneque J C, Camps M, Pérez-Castillo A, Testar X, Palacín M, Santos A, Zorzano A
Departament de Bioquímica i Fisiologia, Facultat de Biologia, Universitat de Barcelona, Spain.
J Biol Chem. 1994 Feb 25;269(8):5905-12.
GLUT1 and GLUT4 glucose transporter expression is highly regulated in muscle and adipose tissue during perinatal life. Here we have investigated the role of thyroid hormones in the regulation of GLUT4 induction and GLUT1 repression associated to neonatal development. Perinatal hypothyroidism markedly impaired GLUT4 protein induction in heart. This effect was heart specific, and a greater expression of GLUT4 was detected in brown adipose tissue from neonatal hypothyroid rats compared with controls. These changes in GLUT4 protein expression were not detected in brown adipose tissue or heart when hypothyroidism was induced in adult rats. These results indicate that GLUT4 induction during perinatal life is highly sensitive to thyroid hormones in both heart and adipose tissue. Perinatal hypothyroidism was characterized by decreased cardiac GLUT4 mRNA concentrations. T3 injection caused a marked increase in cardiac levels of GLUT4 mRNA in hypothyroid neonates. Thus, in 13-day-old hypothyroid rats, GLUT4 mRNA levels increased 3-fold 1 h after T3 injection. Under these conditions, retinoic acid also caused a rapid increase in cardiac GLUT4 mRNA levels from hypothyroid neonates. In addition, cardiac levels of GLUT4 protein markedly increased in fetuses and in neonates 24 h after T3 injection. These findings suggest that a direct effect of thyroid hormones is the promotion of cardiac GLUT4 gene expression. GLUT1 protein expression was markedly enhanced in brown adipose tissue and heart during neonatal hypothyroidism as well as in hypothyroidism induced in adult rats. This was concomitant to greater levels of GLUT1 mRNA in hearts from hypothyroid neonates. Immunofluorescence analysis indicated that cardiomyocytes from hypothyroid pups contained an enhanced level of GLUT1 protein. Furthermore, T3 injection caused a decrease in cardiac levels of GLUT1 mRNA in hypothyroid neonates. These results indicate that thyroid hormone manipulation leads to inverse regulation of GLUT1 and GLUT4 glucose transporter gene expression in the neonatal heart. We conclude that thyroid hormones play a pivotal role controlling the transition of glucose transporter carriers from fetal to neonatal levels in heart and brown adipose tissue.
在围产期,肌肉和脂肪组织中葡萄糖转运蛋白1(GLUT1)和葡萄糖转运蛋白4(GLUT4)的表达受到高度调控。在此,我们研究了甲状腺激素在与新生儿发育相关的GLUT4诱导和GLUT1抑制调控中的作用。围产期甲状腺功能减退显著损害了心脏中GLUT4蛋白的诱导。这种作用具有心脏特异性,与对照组相比,在新生甲状腺功能减退大鼠的棕色脂肪组织中检测到GLUT4的表达更高。当成年大鼠诱导甲状腺功能减退时,棕色脂肪组织或心脏中未检测到GLUT4蛋白表达的这些变化。这些结果表明,围产期心脏和脂肪组织中GLUT4的诱导对甲状腺激素高度敏感。围产期甲状腺功能减退的特征是心脏GLUT4 mRNA浓度降低。注射三碘甲状腺原氨酸(T3)导致甲状腺功能减退新生儿心脏中GLUT4 mRNA水平显著升高。因此,在13日龄的甲状腺功能减退大鼠中,注射T3后1小时GLUT4 mRNA水平增加了3倍。在这些条件下,视黄酸也导致甲状腺功能减退新生儿心脏中GLUT4 mRNA水平迅速升高。此外,胎儿和新生儿在注射T3后24小时心脏中GLUT4蛋白水平显著增加。这些发现表明甲状腺激素的直接作用是促进心脏GLUT4基因表达。在新生儿甲状腺功能减退以及成年大鼠诱导的甲状腺功能减退期间,棕色脂肪组织和心脏中GLUT1蛋白表达显著增强。这与甲状腺功能减退新生儿心脏中GLUT1 mRNA水平升高相伴。免疫荧光分析表明,甲状腺功能减退幼崽的心肌细胞中GLUT1蛋白水平增强。此外,注射T3导致甲状腺功能减退新生儿心脏中GLUT1 mRNA水平降低。这些结果表明,甲状腺激素的调控导致新生儿心脏中GLUT1和GLUT4葡萄糖转运蛋白基因表达的反向调节。我们得出结论,甲状腺激素在控制心脏和棕色脂肪组织中葡萄糖转运载体从胎儿水平向新生儿水平的转变中起关键作用。